AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Clinical Guidelines Updated to Options for Metastatic Disease.(lymphatic metastasis in breast cancer)

Women's Health Weekly

| January 25, 2001 | Henderson, C. W. | COPYRIGHT 2001 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2001 JAN 25 - (NewsRx.com) -- The December 30, 2000, issue of Oncology highlights the updated National Comprehensive Cancer Network (NCCN) breast cancer treatment guidelines featuring a recently approved treatment option for patients with early breast cancer that has spread to their lymph nodes.

The updated guidelines include a chemotherapy treatment known as CEF (cyclophosphamide, epirubicin, and fluorouracil). A landmark trial confirmed that Ellence (epirubicin hydrochloride injection), part of the CEF regimen, increases five-year survival and reduces the risk of cancer recurrence over CMF (cyclophosphamide, methotrexate and fluorouradil), a standard therapy in post-surgical treatment of early breast cancer.

Each year, researchers from the U.S. leading cancer centers under the auspices of the National Comprehensive Cancer Network examine the latest advances in cancer treatment and agree upon specific treatment recommendations. These treatment guidelines serve as the recommended standards of care for the cancer community. The addition of CEF provides another proven treatment option for women whose breast cancer has spread to the lymph nodes.

"These (NCCN) guidelines are evidence-based. The inclusion of this option for women with breast cancer is a result of a comprehensive body of data that demonstrate the efficacy of epirubicin in treating early stage breast cancer. Epirubicin presents a new treatment option in the United States for early breast cancer patients," stated Robert Carlson, MD, NCCN.

The guidelines for physicians are also accompanied by treatment guidelines that have been rewritten for patients (Breast Cancer Treatment Guidelines for Patients, Version III). Available ...

Related articles from newspapers, magazines, journals, and more
"Lower-Income Women with Breast Cancer: Interacting with Cancer Treatment and...
Magazine article from: Resources for Feminist Research Moffat, Sandra March 22, 2006 700+ words
...Gould, Judy. "Lower-Income Women with Breast Cancer: Interacting with Cancer Treatment and Income Security Systems." Canadian...systematically analyze the costs involved in treating breast cancer and how lower-income women try to cope...
FDA Approves ELLENCE(TM), a New Breast Cancer Treatment.
Press release article from: PR Newswire September 16, 1999 700+ words
...s approval of ELLENCE will give women with breast cancer access to a new weapon they can use in their battle against breast cancer." Treatment of Breast Cancer in the United States Adjuvant therapy, a mainstay...
Pharmacia & Upjohn Launches AROMASIN(R) (exemestane tablets) - A New Breast...
Press release article from: PR Newswire January 21, 2000 700+ words
...introduction of AROMASIN closely follows another breast cancer milestone for Pharmacia & Upjohn...the treatment of early node-positive breast cancer. "AROMASIN is the second new breast cancer treatment we've brought to patients in just four...
Black cohosh, breast cancer, and interactions with conventional cancer...
Magazine article from: Townsend Letter: The Examiner of Alternative Medicine Hudson, Tori August 1, 2007 700+ words
...effects of cancer therapy agents on breast cancer cells by the herbal medicine black cohosh. Breast Cancer Res Treat. 2005;90(3):233...vitro study studied commonly used mouse breast cancer cell lines to see if black cohosh extracts...
Black cohosh, breast cancer and interactions with conventional cancer...
Magazine article from: Townsend Letter for Doctors and Patients Hudson, Tori October 1, 2005 700+ words
...the effects of cancer therapy agents on breast cancer cells by the herbal medicine black cohosh. Breast Cancer Res Treat 2005;90(3):233-239. This in vitro study used common mouse breast cancer cell lines to see if black cohosh extracts...
Take steps to protect your heart during cancer treatment: women with breast...
Magazine article from: Heart Advisor October 1, 2008 700+ words
...women are surviving breast cancer, only to develop...before starting cancer treatment," says Cleveland...failure during any cancer treatment, your cardiologist...heart damage from breast cancer treatment, make sure any...
Genistein can undermine breast cancer treatment.
Magazine article from: Nutraceuticals International October 1, 2008 700+ words
...can interfere with a common breast cancer treatment. Women taking aromatase inhibitors to treat breast cancer or prevent its recurrence...inhibitors are a mainstay of breast cancer treatment in post-menopausal women...
New Clinical Data Show Benefits of Femara(R) for Women With Breast Cancer Even...
Press release article from: PR Newswire March 23, 2006 700+ words
...Head of Clinical Services at Breast Cancer Care commented: "Women who...treatment across the entire breast cancer treatment spectrum - before surgery...receptor positive invasive early breast cancer - The treatment of early invasive...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA